Cas 1386859-75-1,ethyl 2-amino-7-[4-(ethoxycarbonyl)phenyl]-3H-1-benzazepine-4-carboxylate

1386859-75-1

Post Buying Request

Basic information

Product Name: ethyl 2-amino-7-[4-(ethoxycarbonyl)phenyl]-3H-1-benzazepine-4-carboxylate
Synonyms: ethyl 2-amino-7-[4-(ethoxycarbonyl)phenyl]-3H-1-benzazepine-4-carboxylate
CAS NO:1386859-75-1
Molecular Formula:
Molecular Weight: 378.428
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: ethyl 2-amino-7-[4-(ethoxycarbonyl)phenyl]-3H-1-benzazepine-4-carboxylate(CAS DataBase Reference)
NIST Chemistry Reference: ethyl 2-amino-7-[4-(ethoxycarbonyl)phenyl]-3H-1-benzazepine-4-carboxylate(1386859-75-1)
EPA Substance Registry System: ethyl 2-amino-7-[4-(ethoxycarbonyl)phenyl]-3H-1-benzazepine-4-carboxylate(1386859-75-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1386859-75-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1386859-75-1 Suppliers

Recommended suppliers

1386859-75-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1386859-75-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,6,8,5 and 9 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1386859-75:
(9*1)+(8*3)+(7*8)+(6*6)+(5*8)+(4*5)+(3*9)+(2*7)+(1*5)=231
231 % 10 = 1
So 1386859-75-1 is a valid CAS Registry Number.

1386859-75-1Upstream product

1386859-75-1Downstream Products

1386859-75-1Relevant academic research and scientific papers

SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS

-

Page/Page column 73-74, (2012/07/28)

Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, fibrotic disease, cardiovascular disease, infectious disease, inflammatory disorder, graft rejection, or graft-versus-host disease.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1386859-75-1